Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Grabbe

Showing results (71-80 of 325) with videos related to

Pageof 33
Sort By:
Dermatologic Therapy|January 31, 2020
Increased risk of angiosarcoma secondary to cancer radiotherapy: Case series and review of the treatment optionsMohamad Goldust, Mario Giulini, Beate Weidenthaler-Barth, et al.
Blood|August 19, 2007
Friend retrovirus infection of myeloid dendritic cells impairs maturation, prolongs contact to naive T cells, and favors expansion of regulatory T cellsSandra Balkow, Frank Krux, Karin Loser, et al.
Journal of Cosmetic Dermatology|August 20, 2021
Combination therapy of recalcitrant severe psoriasis with psoriatic arthritis, diabetes nephropathy, and liver cirrhosisSebastian Zimmer, Mohamad Goldust, Shashank Bhargava, et al.
Journal of Cosmetic Dermatology|November 1, 2021
Non-invasive diagnostic techniques in pigmentary skin disorders and skin cancerYashdeep Singh Pathania, Zoe Apalla, Gabriel Salerni, et al.
Medical Sciences (Basel, Switzerland)|February 20, 2026
Inflammatory Bowel Diseases Are Not Associated with an Increased Risk of Autoimmune ThyroiditisAlexander Barton, Christian Labenz, Stephan Grabbe, et al.
Nanomedicine (London, England)|October 5, 2016
Translating nanoparticulate-personalized cancer vaccines into clinical applications: case study with RNA-lipoplexes for the treatment of melanomaStephan Grabbe, Heinrich Haas, Mustafa Diken, et al.
Cancers|May 14, 2022
The Role of Treatment Sequencing with Immune-Checkpoint Inhibitors and BRAF/MEK Inhibitors for Response and Survival of Patients with BRAFV600-Mutant Metastatic Melanoma-A Retrospective, Real-World Cohort StudyMaximilian Haist, Henner Stege, Ronja Ebner, et al.
Journal of Cosmetic Dermatology|January 14, 2022
Biologic and targeted therapeutics in vitiligoPriyanka Karagaiah, Robert A Schwartz, Torello Lotti, et al.
Toxins|August 26, 2021
Chronic Kidney Disease-Associated PruritusPuneet Agarwal, Vinita Garg, Priyanka Karagaiah, et al.
Journal of Leukocyte Biology|April 26, 2003
Monocyte and macrophage functions in M-CSF-deficient op/op mice during experimental leishmaniasisFrank Schönlau, Christian Schlesiger, Jan Ehrchen, et al.
Pageof 33

Showing results (71-80 of 325) with videos related to

Sort By:
Pageof 33
Dermatologic Therapy|January 31, 2020
Increased risk of angiosarcoma secondary to cancer radiotherapy: Case series and review of the treatment optionsMohamad Goldust, Mario Giulini, Beate Weidenthaler-Barth, et al.
Blood|August 19, 2007
Friend retrovirus infection of myeloid dendritic cells impairs maturation, prolongs contact to naive T cells, and favors expansion of regulatory T cellsSandra Balkow, Frank Krux, Karin Loser, et al.
Journal of Cosmetic Dermatology|August 20, 2021
Combination therapy of recalcitrant severe psoriasis with psoriatic arthritis, diabetes nephropathy, and liver cirrhosisSebastian Zimmer, Mohamad Goldust, Shashank Bhargava, et al.
Journal of Cosmetic Dermatology|November 1, 2021
Non-invasive diagnostic techniques in pigmentary skin disorders and skin cancerYashdeep Singh Pathania, Zoe Apalla, Gabriel Salerni, et al.
Medical Sciences (Basel, Switzerland)|February 20, 2026
Inflammatory Bowel Diseases Are Not Associated with an Increased Risk of Autoimmune ThyroiditisAlexander Barton, Christian Labenz, Stephan Grabbe, et al.
Nanomedicine (London, England)|October 5, 2016
Translating nanoparticulate-personalized cancer vaccines into clinical applications: case study with RNA-lipoplexes for the treatment of melanomaStephan Grabbe, Heinrich Haas, Mustafa Diken, et al.
Cancers|May 14, 2022
The Role of Treatment Sequencing with Immune-Checkpoint Inhibitors and BRAF/MEK Inhibitors for Response and Survival of Patients with BRAFV600-Mutant Metastatic Melanoma-A Retrospective, Real-World Cohort StudyMaximilian Haist, Henner Stege, Ronja Ebner, et al.
Journal of Cosmetic Dermatology|January 14, 2022
Biologic and targeted therapeutics in vitiligoPriyanka Karagaiah, Robert A Schwartz, Torello Lotti, et al.
Toxins|August 26, 2021
Chronic Kidney Disease-Associated PruritusPuneet Agarwal, Vinita Garg, Priyanka Karagaiah, et al.
Journal of Leukocyte Biology|April 26, 2003
Monocyte and macrophage functions in M-CSF-deficient op/op mice during experimental leishmaniasisFrank Schönlau, Christian Schlesiger, Jan Ehrchen, et al.
Pageof 33